HUM vs INSM · P/E 39, rev $129.66B vs rev $363.7M
Humana Inc (HUM) versus Insmed Inc (INSM) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Insmed Inc (INSM) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported INSM revenue for 2024-12-31 was $363.7M. Net income was -$913.8M. Revenue was up 19.2% from 2023-12-31 to 2024-12-31. INSM currently screens at market cap $20.42B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. INSM currently screens at market cap $20.42B.
Not investment advice. Open the HUM and INSM stock pages for the full models.
Not investment advice.